Related Experiment Video

Updated: Jun 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention

Joseph P Lynch1, George G Zhanel

  • 1Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. jplynch@mednet.ucla.edu

Seminars in Respiratory and Critical Care Medicine
|March 20, 2009
PubMed

Insights

Invasive pneumococcal disease (IPD) affects vulnerable populations, with vaccines showing varied effectiveness. Emergence of new serotypes necessitates ongoing research into prevention strategies for this potentially lethal illness.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Vaccinology

Background:

  • Streptococcus pneumoniae causes pneumonia, meningitis, and bacteremia.
  • Invasive pneumococcal disease (IPD) disproportionately impacts young children, older adults, and immunocompromised individuals.
  • IPD has significant case fatality rates, particularly in adults.

Purpose of the Study:

  • To describe the epidemiology and risk factors of IPD.
  • To analyze host- and organism-specific factors influencing IPD outcomes.
  • To discuss the role of vaccines and preventive strategies against IPD.

Main Methods:

  • Review of epidemiological data on IPD.
  • Analysis of serotype prevalence, infectivity, and virulence.
  • Evaluation of vaccine efficacy (pneumococcal polysaccharide vaccine and PCV7).

Main Results:

  • A limited number of S. pneumoniae serotypes cause most IPD cases.
  • Pneumococcal polysaccharide vaccine reduces IPD incidence in at-risk groups but has limited population-wide benefit.
  • PCV7 significantly reduced IPD in children and adults via herd immunity but led to serotype replacement.

Conclusions:

  • Vaccination strategies have impacted IPD incidence, but serotype replacement is a concern.
  • Emergence of more virulent 'replacement' serotypes requires attention.
  • Further research into novel preventive strategies is crucial to combat IPD.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...